---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-23-033545"
form_type: "8-K"
ticker: "BHVN"
cik: "0001935979"
company_name: "Biohaven Ltd."
filed_at: "2023-10-03T23:59:59+00:00"
generated_at: "2026-06-10T05:47:51.653329+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Biohaven establishes $150M at-the-market equity offering program with J.P. Morgan

## Summary
- Agreement with J.P. Morgan Securities allows sale of up to $150M common shares via ATM program.
- Sales may occur on NYSE at prevailing market prices or in negotiated transactions.
- Company may sell shares periodically based on market conditions, capital needs, and other factors.
- Registration statement on Form S-3 filed October 2, 2023 (File No. 333-274822).
- Program provides added flexibility for potential future financing without immediate dilution.

## SEC filing metadata
- accession: 0001628280-23-033545
- form_type: 8-K
- ticker: BHVN
- cik: 0001935979
- company_name: Biohaven Ltd.
- filed_at: 2023-10-03T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1935979/000162828023033545/0001628280-23-033545-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1935979/000162828023033545/bhvn-20231002.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-23-033545
- JSON: https://secwatch.observer/filing/0001628280-23-033545.json
- Plain text: https://secwatch.observer/filing/0001628280-23-033545.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.